Actively Recruiting
Hamburg TranscathEteR Mitral Valve REplacement RegiStry
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2021-06-04
300
Participants Needed
1
Research Sites
512 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Hamburg TranscathEteR Mitral Valve REplacement RegiStry (HERMES) is a prospective clinical cohort registry aiming to gather follow-up information on short- and long-term outcome of patients with mitral valve disease that undergo transcatheter mitral valve replacement (TMVR) screening. In particular, long-term durability and function of implanted bioprosteses is of utmost interest for both patients and clinicians. Moreover, this study aimes to investigate and compare the different treatment strategies patients undergo after successful or unsuccessful screening for TMVR.
CONDITIONS
Official Title
Hamburg TranscathEteR Mitral Valve REplacement RegiStry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide written informed consent following local laws and Good Epidemiological Practice
- Age over 18 years
- Diagnosis of clinically relevant mitral valve disease and undergoing TMVR screening
You will not qualify if you...
- Insufficient German language skills to understand study materials and interviews without translation
- Physical or psychological inability to cooperate with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Heart and Vascular Center Hamburg
Hamburg, Germany, 20246
Actively Recruiting
Research Team
S
Sebastian Ludwig, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here